Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients
- Conditions
- Pulmonary Disease, Chronic ObstructiveLung Diseases, Interstitial
- Registration Number
- NCT04159129
- Lead Sponsor
- Schön Klinik Berchtesgadener Land
- Brief Summary
The aim of this study is to evaluate the effects of a three-week inpatient pulmonary rehabilitation (PR) program on the walking speed in patients with chronic obstructive (COPD) or interstitial lung disease (ILD).
- Detailed Description
At most german traffic light crossings, a walking speed of 1,2m/sec is required to cross the road in time. Patients who are unable to cross the road at this speed, expose themselves to an increased level of stress and possibly the risk of accidents. Thus, they are discouraged from participating in an active social life.
An UK study (Nolan et al., Thorax 2018) showed that only 10.7% of the 926 patients with moderate COPD attained a walking speed of 1.2m/sec. As PR plays a key role in the management of chronic lung diseases in order to improve patients´ exercise capacity, the aim of this study was to evaluate the PR effects on the Walking Speed in patients with COPD or ILD. The investigators hypothesize that PR improves the ability to cross the road in the appropriate time.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 43
- Participation in a pulmonary Rehabilitation program (Schön Klinik BGL)
- Indication: COPD or ILD
- COPD; FEV1 <50%
- ILD: FVC <70%
- written informed consent
- non compliance
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method change of maximum walking speed Day 1 and Day 21 assessed during a walk of 11m
- Secondary Outcome Measures
Name Time Method Change in tension symptoms during a field walk test Day 1 and Day 21 intensity of perceived tension symptoms experienced when crossing a traffic light (VAS scale, ranging from 0 to 10)
Change in walking speed during a field walk test Day 1 and Day 21 measured by the time needed to cross a traffic light (distance: 11m)
Change in Quality of life: Chronic Respiratory Disease Questionnaire (CRQ) Day 1 and Day 21 assessed by the Chronic Respiratory Disease Questionnaire (CRQ)- a 20-item self-report questionnaire; score 1-7; higher scores indicate a better health-related quality of life
Change of usual walking Speed Day 1 and Day 21 assessed during a walk of 11m by using the individual daily life Walking Speed.
Change in maximum leg strength Day 1 and Day 21 measured by the microfet, knee Extension
Change in illness perception Day 1 and Day 21 assessed by the Illness perception Questionnaire, revised (IPQ-R) - 18 items, score 1-5; higher scores indicate a worse illness perception, except of item 7,9,10,11,12.
Change of exercise capacity Day 1 and Day 21 measured by the sit-to-stand test, test duration: 1 minute
Change of frailty (FFP) Day 1 and Day 21 measured by Fried Frailty Phenotype (FFP), including five constructs (weight loss, exhaustion, physical activity, gait speed and weakness); range 0-5, higher scores reflect increased Frailty: A score of 0 is considered as "robust", a score of 1-2 is considered as "pre-frail", a score lower than 2 reflects "Frailty"
Change in anxiety and Depression symptoms Day 1 and Day 21 Anxiety/Depression measured by Hospital Anxiety and Depression Scale (HADS) - a screening questionnaire including seven questions each about Depression and Anxiety; each part ranging from 0 to 21; higher scores indicate higher presence of the respective state
Change in COPD-related fears on disease-specific disability Day 1 and Day 21 assessed by the German "COPD Angst Fragebogen" (CAF) - a 20-item self-report questionnaire, rated on a Lickert-scale (score 0-4); highest maximum score: 80 points; higher scores indicate higher anxiety levels.
Change in balance Day 1 and Day 21 measured by the Leonardo platform
Trial Locations
- Locations (1)
Schön Klinikum Berchtesgadener Land
🇩🇪Schönau am Königssee, Bavaria, Germany